Sandoz Inc. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
| Sandoz Inc. |
| Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc. |
| 1:2024cv01192 |
| October 24, 2024 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 20, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Laura A. Lydigsen, Mark H. Remus for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
| Pro Hac Vice Attorney April Barnard for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Mark H. Remus, Laura A. Lydigsen, and April Barnard. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard )( Payment of $ 150, receipt number ADEDC-4550738).(Gattuso, Dominick) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard - filed by Sandoz Inc.. (Gattuso, Dominick) |
SO ORDERED re #11 MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus, Laura A. Lydigsen and April Barnard filed by Sandoz Inc. ORDERED by Judge Maryellen Noreika on 11/18/2024. (dlw)
|
|
Filing 10
SO ORDERED re #9 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 (Set/Reset Answer Deadlines: Boehringer Ingelheim International GmbH answer due 1/9/2025; Boehringer Ingelheim Pharma GmbH & Co. KG answer due 1/9/2025; Boehringer Ingelheim Pharmaceuticals Inc. answer due 1/9/2025). ORDERED by Judge Maryellen Noreika on 11/4/2024. (dlw)
|
| Filing 9 STIPULATION TO EXTEND TIME for Defendants Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals, Inc. to move, answer, or otherwise respond to the Complaint to January 9, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Tigan, Jeremy) |
| Filing 8 REDACTED VERSION of #2 Complaint and Exhibits E, F and L by Sandoz Inc. (Attachments: #1 Exhibit E, #2 Exhibit F, #3 Exhibit L)(Gattuso, Dominick) Modified on 10/31/2024 (dlw). |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
|
SO ORDERED re #1 MOTION to Seal - IT IS HEREBY ORDERED that the motion is GRANTED and the Complaint and Exhibits E, F & L may be filed under seal. IT IS FURTHER ORDERED that redacted versions of these documents shall be filed no later than 10/31/2024. ORDERED by Judge Maryellen Noreika on 10/25/2024. (dlw)
|
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Other Affiliate Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (oam) |
| Filing 6 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (oam) |
| Filing 5 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/20/2022. Date of Expiration of Patent: See attached. Thirty-Month Stay Deadline - N/A (Declaratory Judgment Action) Modified on 10/31/2024 (dlw). |
| Filing 4 EXHIBITS to #2 Complaint filed by Sandoz Inc. (Attachments: #1 Exhibit B, #2 Exhibit C, #3 Exhibit D, #4 Exhibit G, #5 Exhibit H, #6 Exhibit I, #7 Exhibit J, #8 Exhibit K, #9 Exhibit M, #10 Exhibit N, #11 Exhibit O, #12 Exhibit P, #13 Exhibit Q, #14 Exhibit R, #15 Exhibit S)(oam) |
| Filing 3 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 2 [SEALED] COMPLAINT for Declaratory Judgment of Non-Infringement filed against Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, and Boehringer Ingelheim Pharmaceuticals Inc. (Filing fee $ 405, receipt number ADEDC-4531692) - filed by Sandoz Inc.. (Attachments: #1 Exhibit E, #2 Exhibit F, #3 Exhibit L, #4 Civil Cover Sheet)(oam) |
| Filing 1 MOTION to File Complaint and Exhibits E, F, and L Under Seal - filed by Sandoz Inc. (Attachments: #1 Text of Proposed Order)(oam) |
| Remark: Exit Electronic Copies to Duty Judge MN. (oam) |
| No Summons Issued. (oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
